How Accredo by Evernorth uses data and insights to drive performance for rare therapies

Empowering rare disease care with actionable insights

In the complex world of rare and gene therapies, data is not just an asset—it's a critical tool for driving performance and improving patient outcomes. Accredo provides rare therapy manufacturers with powerful, customizable data insights that enhance decision-making and inform market strategies throughout a product’s lifecycle.

Adaptive insights that power informed strategies

Accredo’s Pharma Hub Portal is a unique, HIPAA-compliant platform that delivers near real-time tracking for therapy performance. This robust tool enables manufacturers to access a wealth of information, from prescription-level detail to trends in therapy adherence and patient outcomes. By offering visibility into each step of the therapy’s journey—from referral and prior authorization to fulfillment—Accredo empowers manufacturers to make informed, data-driven decisions that enhance patient care and market performance.

Whether it’s tracking adherence patterns or identifying shifts in market conditions, these insights enable manufacturers to navigate the complexities of the rare disease landscape with agility and precision.

Streamlined communication for maximum efficiency

One significant advantage of the Pharma Hub Portal is streamlining communication between all stakeholders involved in patient care. The portal integrates with Accredo’s prescriber portal, MyAccredoPatients.com, making it easier for manufacturers, prescribers and pharmacy teams to share information and resolve issues quickly.

93% of queries are resolved by the Pharma Hub Portal without needing to be escalated to a program manager, saving up to 24 hours per week.1

For manufacturers who rely on third-party hubs to manage referrals, Accredo’s Pharma Hub Portal offers even more value. Field agents and program managers gain enhanced visibility into referral counts, helping them track business objectives and better support prescribers and patients.

Shaping the future of rare disease therapies

Accredo’s commitment to providing manufacturers with cutting-edge data and insights is paving the way for better rare disease care. By offering real-time, actionable information and empowering manufacturers to make data-driven decisions, Accredo helps bring therapies to market more efficiently and supports their long-term success. This approach not only improves patient outcomes but also drives innovation across the rare disease landscape.

As the rare therapy market continues to grow, Accredo remains dedicated to helping manufacturers deliver insights that advance care, streamline operations and ensure that patients receive the life-saving treatments they need.

Learn more about how Accredo’s Pharma Hub Portal and data-driven insights can support the success of your rare therapy programs by downloading our full white paper.

• 1

  2023 Accredo Data